Anti-tuberculous therapy-induced crystal arthropathy.
Abraham
S
S
Mitchell
A
A
Cope
A
A
D000368:Aged; D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003460:Crystallization; D004977:Ethambutol / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007592:Joint Diseases / Q000139:chemically induced*; D011718:Pyrazinamide / Q000009:adverse effects / Q000627:therapeutic use; D014394:Tuberculosis, Osteoarticular / Q000188:drug therapy*
D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol